Cognos Therapeutics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Reverse Merger
  • (Cancelled)

  • Latest Deal Amount
  • $124M

Cognos Therapeutics General Information

Description

Cognos Therapeutics Holdings Inc is a medical technology company focused on creating advanced implantable pump devices for neurological and oncological indications. Its goal is to develop devices that adjust the course of therapeutics for the treatment and mitigation of disease models where current technology does not provide an effective solution. Its flagship product, the SINNAIS Implantable Smart Pump (SINNAIS), is the result of over a decade and a half of research and development in the field of implantable drug delivery pumps. SINNAIS represents a platform designed for the future, incorporating microelectronics, communication capabilities, and embedded programmable parameters in its architecture.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10604 South La Cienega Boulevard
  • Inglewood, CA 90304
  • United States
+1 (310)
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Vertical(s)
HealthTech, Oncology
Corporate Office
  • 10604 South La Cienega Boulevard
  • Inglewood, CA 90304
  • United States
+1 (310)

Cognos Therapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cognos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Reverse Merger 03-Jan-2023 $124M Cancelled Generating Revenue
7. Later Stage VC 31-Mar-2022 Cancelled Generating Revenue
6. Later Stage VC 12-Oct-2021 Completed Generating Revenue
5. Angel (individual) 15-Jul-2021 Completed Generating Revenue
4. Later Stage VC 21-May-2021 Completed Pre-Clinical Trials
3. Later Stage VC 29-May-2018 Completed Startup
2. Angel (individual) 20-Apr-2016 $48K $208K Completed Startup
1. Later Stage VC 07-Dec-2015 $160K $160K Completed Startup
To view Cognos Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cognos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cognos Therapeutics Holdings Inc is a medical technology company focused on creating advanced implantable pump devices f
Therapeutic Devices
Inglewood, CA
8 As of 2022

Minneapolis, MN
 

North Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cognos Therapeutics Competitors (2)

One of Cognos Therapeutics’s 2 competitors is Medtronic, a Corporation company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medtronic Corporation Minneapolis, MN
Abbott Corporation North Chicago, IL
You’re viewing 2 of 2 competitors. Get the full list »

Cognos Therapeutics Patents

Cognos Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230191095-A1 Inline pressure and temperature sensor for cerebral shunts Pending 22-Dec-2021
US-20220161076-A1 Method for extinguishing an electrochemical generator in the event of a thermal runaway Pending 15-May-2019
US-20200368428-A1 Hermetic seal for use in an implantable metronomic drug pump and a mehtod of manufacturing the same Inactive 29-Apr-2019
US-20200338325-A1 Method and apparatus for a long-term, fully implantable mri compatible drug pump Active 29-Apr-2019
US-12076527-B2 Method and apparatus for a long-term, fully implantable mri compatible drug pump Active 29-Apr-2019 A61M5/14276
To view Cognos Therapeutics’s complete patent history, request access »

Cognos Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cognos Therapeutics FAQs

  • When was Cognos Therapeutics founded?

    Cognos Therapeutics was founded in 2003.

  • Where is Cognos Therapeutics headquartered?

    Cognos Therapeutics is headquartered in Inglewood, CA.

  • What is the size of Cognos Therapeutics?

    Cognos Therapeutics has 8 total employees.

  • What industry is Cognos Therapeutics in?

    Cognos Therapeutics’s primary industry is Therapeutic Devices.

  • Is Cognos Therapeutics a private or public company?

    Cognos Therapeutics is a Private company.

  • What is Cognos Therapeutics’s current revenue?

    The current revenue for Cognos Therapeutics is .

  • How much funding has Cognos Therapeutics raised over time?

    Cognos Therapeutics has raised $4.8M.

  • Who are Cognos Therapeutics’s competitors?

    Medtronic and Abbott are competitors of Cognos Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »